The role of Foxp3+ regulatory T-cells in endometriosis: A potential controlling mechanism for a complex, chronic immunological condition

Human Reproduction

Volumn 25, Issue 4, 2010, Pages 900-907

  Berbic, Marina ^a   Hey Cunningham, Alison J ^a   Ng, Cecilia ^a   Tokushige, Natsuko ^a   Ganewatta, Subha ^a   Markham, Robert ^a   Russell, Peter ^a   Fraser, Ian S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Endometriosis; Endometrium; Foxp3; Peritoneal lesions; Regulatory T cells

Indexed keywords

ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; ARTICLE; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMPLANT; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PATHOGENESIS; PERITONEAL CAVITY; REGULATORY T LYMPHOCYTE; STROMA; UPREGULATION;

EID: 77949965590     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq020     Document Type: Article

References (42)

1. Akoum A, Metz CN, Al-Akoum M, Kats R. Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain. Fertil Steril 2006;85:1379-1385.
2. Al-Jefout M, Tokushige N, Hey-Cunningham AJ, Manconi F, Ng C, Schulke L, Berbic M, Markham R, Fraser IS. Microanatomy and function of the eutopic endometrium in endometriosis. Expert Rev Obstet Gynecol 2009;4:61-79.
3. Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4 \+, CD25\+ and FOXP3\+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 2007;178:2572-2578.
4. Berbic M, Schulke L, Markham R, Tokushige N, Russell P, Fraser IS. Macrophage expression in endometrium of women with and without endometriosis. Hum Reprod 2009;24:325-332.
5. Bullimore DW. Endometriosis is sustained by tumour necrosis factor-[alpha]. Med Hypotheses 2003;60:84-88.
6. Bulmer JN, Jones RK, Searle RF. Intraepithelial leukocytes in endometriosis and adenomyosis: comparison of eutopic and ectopic endometrium with normal endometrium. Hum Reprod 1998;13:2910-2915.
7. Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Zhou J, Sebastian S Role of aromatase in endometrial disease. J Steroid Biochem Mol Biol 2001; 79:19-25.
8. D'Hooghe TM, Kyama CK, Mihalyi AM, Chai D, Falconer H, Mwenda JM. The baboon model for translational research in endometriosis. Reprod Sci 2009;16:152-161.
9. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998; 13:1689-1690.
10. Fehervari Z, Sakaguchi S. CD4\+ Tregs and immune control. J Clin Invest 2004;114:1209-1217.
11. Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtso V, Nadaf S, Carbone DP. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood Cells 1998;92:4150-4166.
12. Giatromanolaki A, Bates GJ, Koukourakis MI, Sivridis E, Gatter KC, Harris AL, Banham AH. The presence of tumor-infiltrating FOXP3\+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer. Gynecol Oncol 2008;110:216-221.
13. Gilabert-Estelles J, Ramon LA, Espana F, Gilabert J, Vila V, Reganon E, Castello R, Chirivella M, Estelles A. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum Reprod 2007;22:2120-2127.
14. Hasui K, Takatsuka T, Sakamoto R, Su L, Matsushita S. Improvement of supersensitive immunohistochemistry with an autostainer: a simplified catalysed signal amplification system. Histochem J 2002; 34:215-222.
15. Healy DL, Rogers PA, Hii L, Wingfield M. Angiogenesis: a new theory for endometriosis. Hum Reprod Update 1998;4:736-740.
16. Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod 2006;12:301-308.
17. Jones RK, Bulmer JN, Searle RF. Phenotypic and functional studies of leukocytes in human endometrium and endometriosis. Hum Reprod Update 1998;4:702-709.
18. Kibangou Bondza P, Maheux R, Akoum A. Endometriosis-related endometrial dysfunctions. World Endo Soc e-J 2006;8:7-10.
19. Lebovic D, Mueller M, Hornung D, Taylor R. Immunology of endometriosis. Immunol Allergy Clin North Am 2002;22:585-598.
20. Li B, Lalani AS, Harding TC, Luan B, Koprivnikav K, Huan Tu G. Vascular endothelial growth factor reduces intratumoral regulatory t cells and enhances the efficacy of GM-CSF-secreting cancer immunotherapy. Clin Cancer Res 2006;12:6808-6816.
21. Liu Y, Zheng P. FoxP3: a life beyond regulatory T cells. Int J Clin Exp Pathol 2009;2:205-210.
22. Liu W, Putnam AL, Xu-yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4\+ Tregs. J Exp Med 2006;203:1701-1711.
23. Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? Trends Mol Med 2003;9:223-228.
24. Melichar B, Nash MA, Lenzi R, Platsoucas CD, Freedman RS. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3\+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis. Clin Exp Immunol 2000;119:19-27.
25. Nandakumar S, Miller WT, Kumaraguru U. T regulatory cells: an overview and intervention techniques to modulate allergy outcome. Clin Mol Allergy 2009;7.
26. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
27. Oosterlynck DJ, Cornillie FJ, Waer M, Koninckx PR. Immunohistochemical characterization of leucocyte subpopulations in endometriotic lesions. Arch Gynecol Obstet 1993;253:197-206.
28. Ota H, Igarashi S, Tanaka T. Expression of gamma delta T cells and adhesion molecules in endometriotic tissue in patients with endometriosis and adenomyosis. Am J Reprod Immunol 1996;35:477-482.
29. Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 \+ CD25\+ regulatory T cells by promoting their proliferation. Immunology 2006;118:58-65.
30. Robboy SJ, Mutter GJ, Prat J, Bentley R, Russell P. Pathology of the female reproductive tract. London: Churchill Livingstone, Harcourt Publishers Limited, 2002.
31. Roncador G, Brown PJ, Maestre L, Hue S, Mart́inez-Torrecuadrada JL, Ling KL, Pratap S, Toms C, Fox BC, Cerundolo V et al. Analysis of FOXP3 protein expression in human CD4 \+ CD25\+ regulatory T cells at the single-cell level. Eur J Immunol 2005;35:1681-1691.
32. Sakaguchi S. The origin of FOXP3-expressing CD4\+ regulatory T cells: thymus or periphery. J Clin Invest 2003;112:1310-1312.
33. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-787.
34. Salamonsen LA, Lathbury LJ. Endometrial leukocytes and menstruation. Hum Reprod Update 2000;6:16-27.
35. Schulke L, Berbic M, Manconi F, Tokushige N, Markham R, Fraser IS. Dendritic cell populations in the eutopic and ectopic endometrium of women with endometriosis. Hum Reprod 2009;24:1695-1703.
36. Shrifen JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jaffe RB, Taylor RN. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112-3118.
37. Takehera M, Masatsugu U, Yamashita Y, Terai Y, Hung YC, Ueki M. Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol 2004;35:1369-1375.
38. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, Zhu L. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 2002;78:148-153.
39. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci 2002;955:89-100.
40. Thornton AM. T regulatory cells. Curr Biol 2005;15:R582.
41. Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B et al. Deficient 17B-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17B-estradiol. J Clin Endocrinol Metab 1998;83:4474-4480.
42. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007;8:457-462.